Natasha Giordano
CIK 1315585 · Chief Executive Officer · last filed 2025-12-15
Natasha Giordano is a Chief Executive Officer who has filed 25 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for OGEN, was dated Dec 15, 2025. Across all open-market trades the lifetime net is −$62.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $168.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$168.8K
5
25
-$62.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OGEN | Director | — | $0.62 | — | $0 | 1 | 2025-12-15 |
| MTNB | Director | — | $0.78 | — | $0 | 3 | 2023-11-03 |
| PLx Pharma Inc. (PLXP) Delisted | Chief Executive Officer | 5,186 | $0.09 | $451 | $15.0K | 8 | 2022-03-16 |
| ACET | Director | 20,972 | $8.05 | $168.8K | -$77.2K | 9 | 2017-12-11 |
| DENDRITE INTERNATIONAL INC (DRTE) Delisted | Pres., Global Business Unit | 75,204 | — | — | $0 | 2 | 2007-05-03 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-15 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2023-11-03 | MTNB | Grant (A) | — | $0 | EDGAR |
| 2022-11-16 | MTNB | Grant (A) | — | $0 | EDGAR |
| 2022-03-16 | PLx Pharma Inc. (PLXP) Delisted | Buy (P) | +4,100 | $15.0K | EDGAR |
| 2022-02-24 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-02 | MTNB | Grant (A) | — | $0 | EDGAR |
| 2021-08-11 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-20 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-24 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-10-03 | — | Other (J) | −20,972 | $0 |